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Abstract
The importance of the gut microbiota (GM) in disease development has recently received
increased attention, and numerous approaches have been made to better understand this
important interplay. For example, metabolites derived from the GM have been shown to pro-
mote atherosclerosis, the underlying cause of cardiovascular disease (CVD), and to
increase CVD risk factors. Popular interest in the role of the intestine in a variety of disease
states has now resulted in a significant proportion of individuals without coeliac disease
switching to gluten-free diets. The effect of gluten-free diets on atherosclerosis and cardio-
vascular risk factors is largely unknown. We therefore investigated the effect of a gluten-
free high-fat cholesterol-rich diet, as compared to the same diet in which the gluten peptide
gliadin had been added back, on atherosclerosis and several cardiovascular risk factors in
apolipoprotein E-deficient (Apoe-/-) mice. The gluten-free diet transiently altered GM com-
position in these mice, as compared to the gliadin-supplemented diet, but did not alter body
weights, glucose tolerance, insulin levels, plasma lipids, or atherosclerosis. In parallel,
other Apoe-/-mice fed the same diets were treated with ampicillin, a broad-spectrum antibi-
otic known to affect GM composition. Ampicillin-treatment had a marked and sustained
effect on GM composition, as expected. Furthermore, although ampicillin-treated mice were
slightly heavier than controls, ampicillin-treatment transiently improved glucose tolerance
both in the absence or presence of gliadin, reduced plasma LDL and VLDL cholesterol lev-
els, and reduced aortic atherosclerotic lesion area. These results demonstrate that a gluten-
free diet does not seem to have beneficial effects on atherosclerosis or several CVD risk
factors in this mouse model, but that sustained alteration of GM composition with a broad-
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spectrum antibiotic has beneficial effects on CVD risk factors and atherosclerosis. These
findings support the concept that altering the microbiota might provide novel treatment strat-
egies for CVD.
Introduction
GM composition has been shown to be altered and likely impact the development and progres-
sion of numerous conditions including atherosclerosis, obesity, diabetes, and, maybe less sur-
prisingly, coeliac disease (gluten intolerance) [1–5].One of the links connecting GM to
systemic inflammation, and thereby indirectly to development of atherosclerosis, is activation
of the Toll-like receptors (TLR) in the intestine resulting in increased secretion of pro-inflam-
matory cytokines [6]. TLR-4 is mainly stimulated by lipopolysaccharide (LPS) originating
from Gram-negative bacteria, but other GM-derived particles are also capable of stimulating
members of the TLR-family [6,7] and promote atherosclerosis in mouse models [5,8]. High fat
diets have been shown to favour colonization of Gram-negative microbiota in the gut leading
to increased production of LPS [9]. High levels of circulating LPS are correlated to increased
macrophage infiltration in adipose tissue and systemic inflammation, adding to the risk of
developing for instance atherosclerosis [10]. Karlsson et al. suggest a more direct association
between the gut microbiota and the inflammatory state of atherosclerotic patients, where bacte-
ria from the intestinal lumen is phagocytosed by macrophages and then transported directly to
sites of endothelial inflammation, where they along with the macrophage is incorporated into
the atherosclerotic lesions [11]. Thus, in addition to well-known cardiovascular risk factors,
such as dyslipidemia, hypertension and insulin resistance, the GM composition has been sug-
gested to alter CVD risk in human subjects.
The realization that alterations of GM composition and intestinal changes are possible con-
tributors to a number of diseases has attracted significant interest, not only in the scientific
community but also in the society as a whole. This notion has contributed to the large increase
in individuals who have switched to gluten-free diets in the belief that gluten is responsible for
many of the common chronic diseases of our time[12]. Whereas it is clear that a gluten-free
diet benefits patients with coeliac disease and possibly the pre-diabetic state of type 1 diabetes
(T1D) [13], the effects of a gluten-free diet on other types of diseases, such as atherosclerosis, is
largely unknown. In both mice [14] and humans [15] it has been shown that dietary gluten
reduces the abundance of bacteria capable of stimulating the immune system, which in animal
models have been shown to increase the risk of development of inflammatory disease, such as
type 1 diabetes (T1D) [16]. In the gut, both dietary gluten and GM-derived particles have been
suggested to interact with TLRs causing a pro-inflammatory innate immune response [6,7,17–
19]. In comparison with other peptides, the gluten peptide, gliadin, is more resistant to enzy-
matic degradation, which has been suggested to result in prolonged immune-stimulation, lead-
ing to more inflammation [19,20].
In this study, we investigated the effect of gluten-free diet, as compared to the same diet sup-
plemented by the gluten protein, gliadin, on clustering of GM, several cardiovascular risk fac-
tors and atherosclerosis in Apoe-/- mice. The broad-spectrum antibiotic ampicillin, which
markedly alters GM, was used as a positive control. Our results demonstrate that a gluten-free
diet does not seem to have beneficial effects on atherosclerosis or several CVD risk factors, but
that sustained alteration of GM composition with ampicillin has beneficial effects on CVD risk
factors and atherosclerosis.
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Materials and Methods
Ethics statement
Experiments were performed in accordance with the EU directive 2010/63/EU on the Protec-
tion of Vertebrate Animals used for Scientific Purposes, and the Danish Animal Experimenta-
tion Act (LBK 1306 from 23/11/2007 with 2011 amendments). The study was approved by the
Animal Experiments Inspectorate, Ministry of Food and Environment, Denmark.
Animals
Because microbiota is transferred from female mice to her pups, the different diets were admin-
istered to pregnant mice in order to obtain more reliable results from their pups. Twenty preg-
nant B6.129P2-Apoetm1Unc N11 (Apoe-/-) mice (Taconic Europe A/S, Ejby, Denmark) were
randomly divided into four different treatment groups each consisting of five animals. Each
group was fed one of the four diets described below. The single-housed pregnant mice gave
birth to 45 female pups, which at four weeks of age were randomized into cages containing
four to six animals within their respective group. Animals were kept at room temperature in a
twelve hour light cycle. The study continued for a total of 16 weeks from the birth of the pups.
Animals were weighed weekly from weaning at week four. Prior to euthanasia by saline perfu-
sion through the left cardiac ventricle, animals were anaesthetized with a Hypnorm/Dormicum
mixture (0.3 ml SC in a 1:1:2 water solution, Vetapharm Ltd., Sherburn in Elmet, Leeds, UK;
Roche A/S, Hvidovre, Denmark). Animals were subjected to daily visual control and animals
showing signs of illness or misthriving were monitored by an affiliated veterinarian.
Diets and antibiotic treatment
Animals in group one received Western Diet without gluten (D12079B, Research Diets Inc.,
New Brunswick, NJ, USA) and pure tap water. Animals in group two received the same gluten-
free Western Diet supplemented with gliadin (Cat. #D11061501, Research Diets Inc., New
Brunswick, NJ, USA with 1% gliadin; Cat. #G3375, Sigma, St. Louis, MO, USA) and pure tap
water (Table 1). Animals in group three received gluten-free Western Diet containing 1% glia-
din and tap water containing the broad spectrum antibiotic ampicillin (1 g/L) (Ampivet1 vet.,
Boehringer Ingelheim, Copenhagen, Denmark). Animals in group four received gluten-free
Western Diet and tap water containing ampicillin. The dietary concentration of the gluten-
peptide, gliadin, was chosen to best mimic that of ordinary barley-based rodent chow [21]. The
diets were weighed and changed twice weekly. Water was changed twice weekly. Diets and
treatment were consistent throughout the study.
Table 1. Composition of groups.
Ampicillin
- +
Dietary Gliadin - WD (n = 12) WD+A (n = 12)
+ WD+G (n = 9) WD+A+G (n = 12)
Group 1 (WD); Animals received gluten-free Western Diet and tap water. Group 2 (WD+G); Animals
received gluten-free Western Diet with added gliadin and tap water. Group 3 (WD+G+A); Animals received
gluten-free Western Diet with added gliadin and ampicillin in their drinking water. Group 4 (WD+A); Animals
received gluten-free Western Diet and ampicillin in their drinking water.
doi:10.1371/journal.pone.0146439.t001
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Gut microbiota composition
Fecal samples obtained aseptically at week 5 and 16 were analysed by denaturing gradient gel
electrophoresis (DGGE) as previously described by Hufeldt, with a few alterations [22]. In
brief, bacterial DNA was extracted using the QIAamp DNA Stool Mini Kit (Qiagen, Hilden,
Germany). Prior to extraction, samples were homogenized using a FastPrep1-24 (MP, Biome-
dicals, Kem-En Tec A/S, Taastrup, Denmark) for 3 x 20 sec at 5.5 m/sec. Quality and concen-
tration of the extracted DNA was verified on a NanoDrop 1000 Spectrophotometer (Thermo
Scientific, USA). Genetic material was amplified by Polymerase Chain Reaction (PCR), using
primers specific to the V3 region of the 16S rRNA gene. Genetic material was then separated
by means of DGGE on a polyacrylamide gel containing a 30–65% chemical gradient (100% cor-
responds to 7 M urea and 40% formamide). DGGE profiles were analysed using BioNumerics
Version 7.1 (Applied Maths, Sint-Martens-Latem, Belgium) for cluster analysis [Dice similarity
coefficient with a band position tolerance and optimization of 1% using the Unweighted Pair
Group Method with Arithmetic averages clustering algorithm (UPGMA) and Principal Com-
ponent Analysis (PCA)]. GM composition results are presented as PCA-plots obtained from
generated dendrograms.
Glucose and Insulin
Glucose tolerance was evaluated by means of oral glucose tolerance test (OGTT) three times
during the study; at 5, 11 and 16 weeks of age. Mice were fasted for four hours prior to testing
and given a glucose solution (2 g/kg, Fresenius Kabi, Copenhagen, Denmark, concentration
500 g/l) by oral gavage. Blood samples were collected at t = 0, 30, 60, 90, 120 and 180 minutes
post gavage. Glucose levels were measured by transferring 5 μl whole-blood to 500 μl EBIO
buffer and analysing glucose levels by a Biosen glucose auto analyser (Eppendorf, Hamburg,
Germany).
Insulin levels were measured just prior to glucose dosing at all three time points and again
at 30 minutes post dosing in the 16 weeks old animals. Plasma samples were analysed for insu-
lin using the "Ultra-sensitive rat insulin ELISA kit" (Crystal Chem, Downers Grove, IL, USA)
with the modifications that in-house rat insulin standards, prepared using heat-treated rat
plasma, were used.
Total plasma Cholesterol (TPC) and lipoprotein fractions
TPC and lipoprotein fractions were analysed at the Department of Pathology/Lipid Sciences,
Wake Forrest University School of Medicine, Winston-Salem, NC, USA. To obtain sufficient
volumes samples were pooled; two animals per pool and four pools corresponding to a total of
eight animals per group were measured. TPC levels were measured using colorimetric enzy-
matic assays as previously described [23–25]. An aliquot of plasma containing approximately
20 μg of TPC was diluted in phosphate buffered saline (PBS) into a final volume of 400 μL for
lipoprotein measurement. Samples were injected onto a Superose 6 HR 10/30 (Amersham
Pharmacia) chromatography column after centrifugation and were run at 0.4 mL/min. The sig-
nal was integrated using Chrom Perfect Spirit Software (Justice Laboratory Software). By mul-
tiplying the TPC concentration by the cholesterol percentage within the elution region for each
lipoprotein class VLDL-, LDL-, and HDL-cholesterol were determined.
Biomarker of oxidative stress
Malondialdehyde (MDA) was used as a biomarker of lipid oxidation and was measured in
plasma by HPLC with fluorescent detection as previously described [26].
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En face aortic plaque assessment
In connection with euthanasia, heart and aorta were gently flushed with 10 ml 0.9% saline. The
thoracic aorta from the base of the heart to the 7th rib was mechanically cleaned of visceral fat
under light microscope, cut open, and placed on glass slides. Slides were photographed under a
microscope and images were subsequently analysed using an image analysis tool (Visio-
morph™, VIS—Visiopharm Integrator System, Hoersholm, Denmark). Plaque burden was
expressed percentagewise as plaque area divided by the total tissue area.
Histological analysis of neutral lipid accumulation in the aortic sinus
After trans-cardiac perfusion, the heart and 1–2 mm of the aortic root were fixed in 10%
buffered formalin for 24 hours and then transferred to 20% sucrose in PBS for 24 hours. The
hearts were trimmed by removing the lower part of the heart with the cutting axis perpendic-
ular to the aortic root. The trimmed hearts were placed in a cryo mold with the cut surface at
the bottom of the mold, cryo fixed in OCT compound (Tissue-Tek, Sakura Finetek, Copen-
hagen, Denmark) and frozen on dry ice. Sections were cut and discarded until the appearance
of the aortic valve. Hereafter, all sections were cut at 10 μm thickness and were collected and
placed on numbered glass slides (SuperFrost1Plus, Hounisen, Skanderborg, Denmark),
three on each glass slide with a distance of 150 μm between the sections, a total of 15 slides
covering a distance of 450 μm. Three slides with three sections on each slide from every ani-
mal were selected for oil red O staining (Sigma-Aldrich). The first slide was selected at ran-
dom between slide no. 1 to 5 and the next two slides were selected 5 and 10 slides apart. The
selected oil red O-stained glass slides were scanned on a digital slide scanner (Hamamatsu
NanoZoomer 2.0 HT) at a 40X magnification and the oil red O-stained area was measured
using an image analysis tool (Visiomorph™). The percent of oil red O-stained area was calcu-
lated as mean of the stained area divided by the total aortic cross-sectional area of the 9
sections.
Statistics
All statistics were calculated using GraphPad Prism 6 (GraphPad Software, San Diego, CA,
USA). Gaussian distribution of the data was measured with D’Agostino & Pearson omnibus
normality test. Data assuming Gaussian distribution were analysed by two-way analysis of
variance (ANOVA) with source of variation. Data not assuming Gaussian distribution were
analysed by Kruskal-Wallis test with Dunn’s multiple comparisons test using WD as control
group. A p-value< 0.05 was considered significant. Statistical analysis of body weight and
OGTT was performed on area under the curve (AUC) values. AUC data over time was ana-
lysed with paired t-test when assuming Gaussian distribution and with Wilcoxon matched-
pairs signed rank test when failing to assume Gaussian distribution. Statistical analysis of GM
composition was performed on entry coordinates obtained from PCA. Samples were com-
pared in a multidimensional manner, and PCA plots depict samples using the three axes with
biggest differences in the entry-coordinates of the single sample. These entry coordinates were
used for statistical analysis, and groups were considered different if they were significantly dif-
ferent in minimum one of the three axes (X, Y, Z equalling P1, P2 and P3). Insulin values and
plasma cytokine values below detectable limits were given the value of half the lower limit of
quantification (LLOQ).
Effect of Gut Flora on Blood Glucose and Atherosclerosis
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Results
Ampicillin was a strong modulator of GM composition in the presence
and absence of the gluten protein gliadin, whereas a gluten-free diet lost
its impact on GM over time in Apoe-/-mice
To avoid biased clustering of the GM samples simply due to animals being housed together,
animals within each group were divided into more than one cage. In addition, fecal samples
were randomized prior to being analysed to avoid biased clustering depending on which gel
the samples were run on.
When analysing entry coordinates obtained from the PCA plots, both ampicillin-treatment
(PC1: p = 0.0005 and PC2: p = 0.0012) and dietary gliadin (PC1: p = 0.0197) strongly influ-
enced GM in the young animals at five weeks of age (Fig 1A and 1B). When the mice reached
16 weeks of age, gliadin had lost its impact on GM composition, and only clustering depending
on ampicillin-treatment was significant (PC1: p = 0.0033 and PC3: p = 0.0355, Fig 1C and 1D).
These results showed that the broad-spectrum antibiotic ampicillin had marked and sustained
effects on the GM composition, whereas a gluten-free diet had only transient effects.
Ampicillin-treated Apoe-/-mice gained more weight than untreated
controls, whereas a gluten-free diet had no effect
Ampicillin treated animals had slightly but significantly higher body weights as well as weight
gain than untreated animals (p = 0.0366 and p = 0.0421 respectively, Fig 2A and 2B). The glu-
ten-free diet had no effect on body weight gain.
Ampicillin-treatment resulted in a transient improvement of glucose
tolerance and reduced insulin levels in Apoe-/-mice, whereas a gluten-
free diet had no effect
We found that glucose tolerance was improved due to ampicillin treatment in 5 and 11 weeks
old animals (p = 0.0114 and p = 0.0095, respectively, Fig 3A–3B and 3D–3E) whereas no differ-
ence in glucose tolerance was observed in the 16 weeks old animals (Fig 3C–3F). When assess-
ing data over time (Fig 3G–3J) a significantly better glucose tolerance was observed in the
young ampicillin-treated animals 5 weeks of age, as compared with data on the same animals
at older ages (11 and 16 weeks of age; p = 0.0210 and p = 0.0467, respectively, Fig 3J).
The gluten-free diet did not alter glucose tolerance in the animals, but at 11 and 16 weeks of
age, a significant interaction between gliadin and ampicillin was observed (p = 0.0099 and p = 0
0.0338 respectively), suggesting that gliadin at these time points might have a differential
impact on glucose tolerance depending on the presence or absence of ampicillin
Insulin data mirrored glucose data closely, as ampicillin-treated animals had significantly
lower basal insulin levels early in life than non-treated animals (WD vs. WD+A at five weeks of
age; p = 0.0221, Fig 4A), an effect which was lost as the animals grew older (Fig 4B and 4C).
Due to the small body size of the animals, repeated insulin measurements during OGTTs were
only possible in the 16 weeks old animals in this study. We found a significant increase in insu-
lin levels 30 minutes after glucose administration in the ampicillin-treated animals compared
to the untreated animals (p = 0.0051, Fig 4D). Gluten-free diet had no effect on insulin levels,
as compared to the gliadin-supplemented diets. No differences in levels of glycated hemoglobin
(HbA1c) could be demonstrated between the groups and all measurements fell within the nor-
mal physiological range (S1 Fig). Furthermore, there were no differences between the four
groups in plasma endotoxin or cytokine levels (S2 and S3 Figs). Together, these results
Effect of Gut Flora on Blood Glucose and Atherosclerosis
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Fig 1. A gluten-free diet results in transient effects on the clustering of gut microbiota, whereas ampicillin has sustained effects. A-B Principal
component analysis (PCA) plots of the GM at 5 weeks of age showing significantly differences between the groups depending on both gliadin and ampicillin-
treatment (PC1; Gliadin: p = 0.0197 and ampicillin: p = 0.0005, PC2; Ampicillin: p = 0.0012). C-D PCA plots of the GM at 16 weeks of age showing
significantly differences between the groups depending on ampicillin treatment (PC1; Ampicillin: p = 0.0033, PC3; Ampicillin: p = 0.0355). (Red: WD, light
red: WD+G, light blue: WD+G+A, blue: WD+A).
doi:10.1371/journal.pone.0146439.g001
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suggested that altered GM composition induced by ampicillin-treatment had beneficial effects
on glucose metabolism, without reducing systemic inflammation.
Ampicillin-treated Apoe-/-mice had lower cholesterol, LDL and VLDL
cholesterol levels
TPC measured in the 16 weeks old animals showed significantly lower cholesterol levels in
ampicillin-treated animals, as compared with untreated animals (p = 0.0064, Fig 5A), which
was caused by significantly different levels of LDL and VLDL (p = 0.0320 and p = 0.0096
respectively, Fig 5C and 5D). No difference in HDL levels could be demonstrated (Fig 5B). The
absence of gluten had no significant effect on plasma lipid levels, as compared to the gliadin-
supplemented diet (Fig 5A–5E). These results demonstrated that ampicillin-treatment had
beneficial effects on LDL and VLDL levels.
Gliadin shifted the ratio between LDL and VLDL in ApoE-/-mice
Dietary gliadin had a significant effect on VLDL fractions (%) in plasma (Fig 5E–5H). No dif-
ference could be shown in HDL fractions between the groups, but gliadin tended to increase
the % of LDL cholesterol (p = 0.0649, Fig 5G) and resulted in a significant reduction of the % of
VLDL cholesterol (p = 0.0161, Fig 5H).
Ampicillin-treatment of Apoe-/-mice resulted in protection from aortic
lesion development, whereas a gluten-free diet had no beneficial effect
The results discussed above show that ampicillin-treatment improved several risk factors of
cardiovascular disease. In order to evaluate whether ampicillin or the gluten-free diet, as com-
pared with the gliadin-supplemented diet, would affect atherosclerosis in Apoe-/- mice, we mea-
sured atherosclerotic lesion area in en face thoracic aorta preparations and neutral lipid
accumulation in the aortic sinus. Consistent with the reduced levels of LDL and VLDL, ampi-
cillin-treated mice exhibited smaller atherosclerotic lesions in the thoracic aorta (p = 0.0285,
Fig 6A). Due to the fact that plasma samples were pooled from several animals for the lipopro-
tein analysis, it was not possible to correlate the levels of LDL and VLDL with atherosclerosis.
Fig 2. Body weights are increased by ampicillin, but not by a gluten-free diet. A Total body weight (g) from weaning until study termination at 16 weeks
of age.B Pure weight gain from 5 weeks of age until termination at 16 weeks of age. Animals receiving ampicillin in their drinking water (WD+G+A andWD
+A) had significantly higher body weight and pure weight gain (both AUC) compared to non-treated animals (p = 0.0366 and p = 0.0421, respectively).
(Graphs depicted with mean ± SEM).
doi:10.1371/journal.pone.0146439.g002
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Fig 3. Glucose tolerance is transiently improved by ampicillin, but not by a gluten-free diet. A-CGlucose levels during oral glucose tolerance tests.
D-FOral glucose tolerance test performed at 5 and 11 weeks of age showed significant difference between the groups with ampicillin-treated animals having
lower AUC levels than untreated animals (p = 0.0114 and p = 0.0095 respectively), whereas no differences could be demonstrated between the groups at 16
weeks of age. Gliadin did not influence glucose tolerance at any time point.G-JDevelopment of glucose tolerance (AUC data) in the four groups over time
show no difference over time in the WD, WD+G andWD+G+A groups but significant better glucose tolerance in the young ampicillin-treated animals (WD+A)
Effect of Gut Flora on Blood Glucose and Atherosclerosis
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The gluten-free diet had no beneficial effects on atherosclerosis, as compared with the gliadin-
supplemented diet (Fig 6A).
The ability of ampicillin to exert protective effects on atherosclerosis did not appear to be
due to improved oxidative stress, measured as MDA levels (Fig 6B), or reduced neutral lipid
accumulation in lesions, measured as oil red O-staining of lesions in the aortic sinus (Fig 6C).
Representative cross sections of sinus lesions are shown in Fig 6D. These lesions exhibited fea-
tures of complex lesions with necrotic cores and cholesterol clefts. Furthermore, levels of
mRNA of several cytokines and other mediators of atherosclerosis were largely unchanged in
mice treated with ampicillin, except for reductions in aortic Ccl2 and Icam1mRNA levels (S4
Fig). No differences in inflammatory markers or LPS could be demonstrated in this study (S2,
S3 and S4 Figs). Thus, ampicillin-treatment was likely to reduce atherosclerosis at least in part
by lowering LDL and VLDL levels and perhaps by reducing inflammatory mediators in the
artery wall.
at 5 weeks of age compared to when they are 11(p = 0.0210, Wilcoxon matched-pairs signed rank test) and 16 (p = 0.0467, paired t test) weeks old,
respectively. (Graphs depicted with mean ± SEM).
doi:10.1371/journal.pone.0146439.g003
Fig 4. Insulin levels are lowered by ampicillin, but not by a gluten-free diet. A-C Insulin levels (t = 0) differed significantly between the groups at 5weeks
of age with ampicillin-treated animals having lower levels than untreated animals (p = 0.0221, Kruskal-Wallis test (WD vs. WD+A)), whereas no differences
could be demonstrated between the groups at 11 or 16 weeks of age.D At 16 weeks of age ampicillin-treated animals had significantly increased insulin
levels 30 minutes after oral glucose administration compared to untreated animals (p = 0.0051, Kruskal-Wallis test (WD vs. WD+A)). Gliadin did not influence
insulin levels at any time point. (Graphs depicted with mean ± SEM).
doi:10.1371/journal.pone.0146439.g004
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Discussion
The findings of this study demonstrated that a gluten-free diet, as compared to a diet supple-
mented with one of the two major peptides present in gluten, gliadin, had transient effects on
GM composition, but did not significantly alter the cardiovascular risk factors we measured or
atherosclerosis in Apoe-/- mice. The effects of gliadin on GM composition are supported by pre-
vious studies [27]. Although we have previously shown a more prolonged effect of gluten on
GM composition by culturing GM in vitro [28], in this study, gliadin lost its impact at 16 weeks
of age. Natural changes in GM occurring with age may influence the metabolic measurements
such as fasting blood glucose values. Gluten-free diets have received extensive interest by the
popular press, a multibillion-dollar food industry, and an increasing proportion of individuals
without coelic disease as the latest trend in healthy diets. Whereas it is clear that patients with
coeliac disease and gluten intolerance benefit from such a diet, the beneficial effects in individ-
uals without coeliac disease on cardiovascular risk is unknown. Our study failed to identify any
positive effects of a gluten-free diet in Apoe-/- mice. One potential caveat is that we only tested
one of the two major peptides present in gluten. Although gliadins are believed to be the most
likely gluten component to exert inflammatory effects, we cannot rule out that other compo-
nents of gluten, e.g. glutinins would have an atherogenic effect. Furthermore, our study was
performed using the Apoe-/- mouse, one of the most used animal models for investigating
pathophysiological as well as mechanistic aspects of atherosclerosis development since its crea-
tion in the mid-nineties [29,30]. As with all animal models developed to mimic human disease,
the Apoe-/- mouse pose a number of translational issues, and compared to humans the Apoe-/-
mouse differs in cholesterol metabolism, lipid profile and plaque pathology including lack of
Fig 5. Total plasma cholesterol, LDL and VLDL are reduced by ampicillin, but not by a gluten-free diet. A Total plasma cholesterol levels measured at
16 weeks of age showed significantly lower levels in ampicillin-treated animals compared to untreated animals (WD vs. WD+A; p = 0.0064). B-D Lipoproteins
(total values) showing significantly group differences in LDL and VLDL levels (p = 0.0320 and p = 0.0096 respectively).E Percentage-wise distribution
(stacked) of the lipoprotein fractions HDL, LDL and VLDL. F-H Lipoprotein fractions (percentages) showing significantly lower VLDL percentages in animals
receiving gliadin in their diet compared to gluten-free fed animals (p = 0.0161). Dots represent pooling of samples from two animals. Due to small group sizes
(n = 8 in all four groups) data were analysed using Kruskal-Wallis test with Dunn’s multiple comparisons test with WD as control group. (Graphs depicted with
mean ± SEM).
doi:10.1371/journal.pone.0146439.g005
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progression into thrombotic occlusions [29]. Our findings in this mouse model would there-
fore have to be validated in human subjects.
In contrast to our findings on gluten-free diets and gliadin-supplemented diets, ampicillin
caused marked and sustained changes in GM composition, consistent with previous studies
[28,31–34]. Ampicillin is a broad spectrum antibiotic eradicating primarily Gram positive but
also Gram negative bacteria and its altering effects on GM composition is therefore not surpris-
ing [33]. GM is capable of modulating the dietary lipid digestion and uptake both directly and
indirectly via metabolites [35]. For instance, GM-derived exopolysaccharides have clearly doc-
umented hypocholesterolemic effects [36]. In a study by Wang et al the important role of GM
in formation of the atherogenic metabolite trimethylamine N-oxide from dietary choline was
demonstrated [5]. Our findings of reduced aortic atherosclerosis in ampicillin-treated mice are
in agreement with these previous studies. Antibiotic treatment has previously been shown to
have growth enhancing abilities [31,37], which was also confirmed by our study. The effects of
ampicillin on plasma lipid levels is more complex. Ampicillin has been reported to result in
cholesterol accumulation, and in a study by Miyata and colleagues, using smaller group sizes of
chow fed male farnesoid X receptor (Fxr)-null mice and wild-type C57BL/6N mice, ampicillin
treatment resulted in increased plasma cholesterol concomitant with reduced fecal cholesterol
excretion [38]. These reports tend to contradict our findings of an apparent cholesterol lower-
ing effect of ampicillin, but the role of GM in lipid metabolism is complex and the reason for
the apparent beneficial effect on metabolic parameters in this study may have been a result of
Fig 6. Ampicillin reduces aortic atherosclerosis without affecting MDA levels. A Plaque burden assessed with the “en face”-method showed
significantly lower plaque burden in the thoracic aorta in ampicillin-treated animals compared to untreated animals (p = 0.0285).BMDA levels measured at
16 weeks of age did not show any differences between the groups.C Histological assessment of the oil red O-positive area at the aortic sinus did not show
any differences between the groups.D Histological slide of three representative aortic sinus lesions, demonstrating complex lesions with cholesterol clefts
and necrotic cores (40X, Stained with Oil Red O). (Graphs depicted with mean ± SEM).
doi:10.1371/journal.pone.0146439.g006
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the altered GM composition that we also observed. It has been suggested by others that the
GM, through initiation of systemic inflammation, contribute to development of atherosclerosis
and that antibiotic treatment reduces LPS levels as well as inflammation in mesenteric adipose
tissue [11,34]. However, no differences, or minimal differences, in inflammatory markers, LPS
or the oxidative stress marker MDA could be demonstrated in our study, and therefore, the
reduction in plasma cholesterol levels may be a more reasonable explanation for our findings.
Precisely how GM-alterations mediated the effects on glucose tolerance, plasma cholesterol lev-
els and atherosclerosis needs further investigation.
In line with previous findings [32–34,39,40], ampicillin improved glucose tolerance in the
early life of the animals. The lower basal insulin levels of ampicillin treated animals were lost
over time. This is in accordance with one of our previous studies, in which ampicillin, if given
for a shorter period after birth or at twelve weeks of age, only had a reducing impact on glucose
tolerance in the early period [32]. Therefore, the effect observed later in life in studies with lon-
ger duration of treatment regimens [39,41] probably was due to the treatment being initiated
in early life. Depletion of the Gram negative component of the GM has been shown to result in
improved glucose tolerance in mice [39,41], and as proposed in a previous study [32], this
improvement may simply be due to a decreased number of Gram-negative bacteria leading to
reduced transfer of LPS to the systemic circulation, although we were not able to demonstrate
differences in LPS levels in plasma.
Conclusions
In this study we showed that a gluten-free diet had no beneficial effects on atherosclerosis or
several CVD risk factors in the Apoe-/- mouse model of atherosclerosis, but that sustained alter-
ation of GM composition with a broad-spectrum antibiotic had beneficial effects on CVD risk
factors as well as atherosclerosis. These findings support the concept that altering the micro-
biota might provide novel treatment strategies for CVD and suggest that GM composition
should not be ignored or underestimated in studies on metabolic disease or atherosclerosis.
Supporting Information
S1 Fig. Glycated hemoglobin (HbA1c).HbA1c was measured three times during the study;
when the animals were 5, 11 and 16 weeks of age. Whole-blood samples were collected from
the tail vein and stabilized in Hemolyzing Reagent (Roche/Hitachi, Mannheim, Germany)
before being analysed on a Cobas 6000 according to manufacturer’s instructions. No differ-
ences could be demonstrated between the groups and all measurements fell within the normal
physiological range.
(TIF)
S2 Fig. Lipopolysaccharide (LPS). LPS was measured three times during the study; when the
animals were five, 11 and 16 weeks of age. Serum samples were analysed using the Plasma con-
tents of LPS were measured using the Pyro-Gene Recombinant Factor C Endotoxin Detection
System (Lonza, Basel, Switzerland) according to manufacturer’s instructions and as previously
described [32]. No differences could be demonstrated between the groups.
(TIF)
S3 Fig. Plasma cytokines. Plasma cytokine levels (IL-1α, IL-2, IL-4, IL-5, IL-6, IL-10, IL-
12p70, IL-17, IL-18, GM-CSF, INFγ, and TNFα) were measured three times during the study;
when the animals were five, 11 and 16 weeks of age. Plasma cytokines were measured with the
Mouse Th1/Th2 10plex Kit FlowCytomix (#BMS820FF), Mouse IL-12p70 FlowCytomix Sim-
plex Kit (#BMS86004FF) and Mouse IL-18 FlowCytomix Simplex Kit (#BMS8618FF, all
Effect of Gut Flora on Blood Glucose and Atherosclerosis
PLOS ONE | DOI:10.1371/journal.pone.0146439 January 22, 2016 13 / 16
eBioscience, Bender MedSystems GmbH, Vienna, Austria). The assay was performed accord-
ing to manufacturer’s instructions. Analysis was run as previously described [32] on a BD Facs-
Canto Flow Cytometer (BD Biosciences, Albertslund, Denmark) and processing of data was
performed using the FlowCytomixTM Pro 2.3 Software (Bender MedSystems). Due to low sen-
sitivity of the commercial kit used, the majority of data fell below detectable limit. With the
inclusion criteria of minimum half of the samples being above detection limit within every
group at a given time, it was only possible to analyse IL-5 at age 11 and 16 weeks, IL-6 at age 16
weeks and IL-10 at age 16 weeks. Due to lack of Gaussian distribution data were analysed using
the non-parametric Kruskal-Wallis test with Dunn’s multiple comparisons test with WD and
the control group. No significant group differences could be demonstrated.
(TIF)
S4 Fig. Gene expressions in the aortic arch. Thoracic aortas were placed in RNAlater1
(#R0901, Sigma, St. Louis, MO 63103, USA) and kept at -80°C. They were then analysed by
Real-Time Quantitative PCR as previously described by Kanter et al [42]. 18S was used as posi-
tive control. Following genes were analysed: Abca1, Abcg1, Acsl1, Ccl2, Cd11b, Cd68, Emr1,
Il1b, Il6, Icam1, Vcam1 and Tnfa (S4A–S4M Fig). Primer sequences can be obtained on
request. Amongst the analysed genes a significant interaction was seen in regulation of the
Abca1 gene meaning that gliadin had a different effect depending on the presence of ampicillin
or vice versa (p = 0.0256). Ccl2 was significantly down-regulated in the ampicillin-treated ani-
mals (WD+A) compared to the untreated animals (WD) (p = 0.0455). Icam1 was significantly
down-regulated in animals receiving both gliadin and ampicillin compared to the untreated
animals (WD) (p = 0.0141). Only Abcg1 data qualified as being normally distributed and was
analysed by 2-way ANOVA. All other data were analysed by Kruskal-Wallis test with Dunn’s
multiple comparison test (WD as control group).
(TIF)
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